141 related articles for article (PubMed ID: 28484155)
1. [Interdigitating dendritic cell sarcoma successfully treated with ABVD therapy in which serum CEA levels correlated with disease activity].
Sakemura R; Hiraga J; Kitagawa S; Ito M; Kajiguchi T; Mizuno S
Rinsho Ketsueki; 2017; 58(4):292-297. PubMed ID: 28484155
[TBL] [Abstract][Full Text] [Related]
2. Complete Remission in Systemic Skin Interdigitating Dendritic Cell Sarcoma after ABVD Chemotherapy.
Kyogoku C; Seki M; Ogawa S; Miyamoto K; Ito Y; Kurita N; Yokoyama Y; Sakata-Yanagimoto M; Obara N; Hasegawa Y; Fujishima F; Ichinohasama R; Nakamura S; Chiba S
J Clin Exp Hematop; 2015; 55(1):33-7. PubMed ID: 26106005
[TBL] [Abstract][Full Text] [Related]
3. [Interdigitating dendritic cell sarcoma-a case report with literature review].
Gao WJ; Zhang R; Qiu HX; Shen YM; Zhang XH; Xue SL; Han Y
Zhonghua Xue Ye Xue Za Zhi; 2005 Apr; 26(4):232-4. PubMed ID: 15949268
[TBL] [Abstract][Full Text] [Related]
4. Interdigitating dendritic cell sarcoma: a rare malignancy responsive to ABVD chemotherapy.
Olnes MJ; Nicol T; Duncan M; Bohlman M; Erlich R
Leuk Lymphoma; 2002 Apr; 43(4):817-21. PubMed ID: 12153170
[TBL] [Abstract][Full Text] [Related]
5. Interdigitating dendritic cell sarcoma of the spleen with hepatic failure after chemotherapy: A case report.
Zhao C; Xie X; Gai DZ; Wu D; Xin H; Yang T
Medicine (Baltimore); 2019 May; 98(19):e15535. PubMed ID: 31083204
[TBL] [Abstract][Full Text] [Related]
6. Interdigitating dendritic cell sarcoma located in the groin: a case report and literature review.
Wang HT; Xu HY; Zhang R; Liu ZG; Zhang GJ
J Int Med Res; 2018 Nov; 46(11):4791-4799. PubMed ID: 30222020
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of disseminated interdigitating dendritic cell sarcoma with adriamycin, bleomycin, vinblastine, and dacarbazine chemotherapy.
Lee SY; Lee SR; Chang WJ; Kim HS; Kim BS; Kim IS
Korean J Hematol; 2012 Jun; 47(2):150-3. PubMed ID: 22783364
[TBL] [Abstract][Full Text] [Related]
8. [Interdigitating dendritic cell sarcoma of lower extremities resistant to high dose chemotherapy BEAM with peripheral blood stem cell transplantation].
Adam Z; Veselý K; Krejcí M; Pour L; Fakan F; Soumarová R; Neubauer J; Vanícek J; Cerný J; Kren L; Bolcák K; Smardová L; Hájek R; Mayer J
Vnitr Lek; 2009 Feb; 55(2):147-57. PubMed ID: 19348397
[TBL] [Abstract][Full Text] [Related]
9. Interdigitating dendritic cell sarcoma of the tonsil.
Kim SY; Kang JH; Chun SH; Chang MH; Kim YS; Lee SN; Kim MS; Kang CS
Asia Pac J Clin Oncol; 2010 Sep; 6(3):144-8. PubMed ID: 20887493
[TBL] [Abstract][Full Text] [Related]
10. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
Duggan DB; Petroni GR; Johnson JL; Glick JH; Fisher RI; Connors JM; Canellos GP; Peterson BA
J Clin Oncol; 2003 Feb; 21(4):607-14. PubMed ID: 12586796
[TBL] [Abstract][Full Text] [Related]
11. [Sustained remission of blastic plasmacytoid dendritic cell neoplasm with ABVD chemotherapy].
Tanikawa S; Sakuranaka H; Chong JM; Okada Y; Takimoto M
Rinsho Ketsueki; 2012 Feb; 53(2):246-51. PubMed ID: 22450587
[TBL] [Abstract][Full Text] [Related]
12. ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned.
Viviani S; Zinzani PL; Rambaldi A; Brusamolino E; Levis A; Bonfante V; Vitolo U; Pulsoni A; Liberati AM; Specchia G; Valagussa P; Rossi A; Zaja F; Pogliani EM; Pregno P; Gotti M; Gallamini A; Rota Scalabrini D; Bonadonna G; Gianni AM; ; ;
N Engl J Med; 2011 Jul; 365(3):203-12. PubMed ID: 21774708
[TBL] [Abstract][Full Text] [Related]
13. ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results.
Bonadonna G; Bonfante V; Viviani S; Di Russo A; Villani F; Valagussa P
J Clin Oncol; 2004 Jul; 22(14):2835-41. PubMed ID: 15199092
[TBL] [Abstract][Full Text] [Related]
14. Interdigitating dendritic cell sarcoma: case report with review of the literature.
Zhou J; Zhou W; Bai C; Zhou Y; Wang Y
Onkologie; 2011; 34(11):634-7. PubMed ID: 22104162
[TBL] [Abstract][Full Text] [Related]
15. Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas.
Gounder M; Desai V; Kuk D; Agaram N; Arcila M; Durham B; Keohan ML; Dickson MA; D'Angelo SP; Shukla N; Moskowitz C; Noy A; Maki RG; Herrera DA; Sanchez A; Krishnan A; Pourmoussa A; Qin LX; Tap WD
Eur J Cancer; 2015 Nov; 51(16):2413-22. PubMed ID: 26298731
[TBL] [Abstract][Full Text] [Related]
16. High-Risk, Advanced-Stage Hodgkin Lymphoma: The Impact of Combined Escalated BEACOPP and ABVD Treatment in Patients Who Rapidly Achieve Metabolic Complete Remission on Interim FDG-PET/CT Scan.
Kedmi M; Apel A; Davidson T; Levi I; Dann EJ; Polliack A; Ben-Bassat I; Nagler A; Avigdor A
Acta Haematol; 2016; 135(3):156-61. PubMed ID: 26588173
[TBL] [Abstract][Full Text] [Related]
17. ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial.
Federico M; Luminari S; Iannitto E; Polimeno G; Marcheselli L; Montanini A; La Sala A; Merli F; Stelitano C; Pozzi S; Scalone R; Di Renzo N; Musto P; Baldini L; Cervetti G; Angrilli F; Mazza P; Brugiatelli M; Gobbi PG;
J Clin Oncol; 2009 Feb; 27(5):805-11. PubMed ID: 19124807
[TBL] [Abstract][Full Text] [Related]
18. Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group.
Meyer RM; Gospodarowicz MK; Connors JM; Pearcey RG; Bezjak A; Wells WA; Burns BF; Winter JN; Horning SJ; Dar AR; Djurfeldt MS; Ding K; Shepherd LE; ;
J Clin Oncol; 2005 Jul; 23(21):4634-42. PubMed ID: 15837968
[TBL] [Abstract][Full Text] [Related]
19. Early versus late intensification for patients with high-risk Hodgkin lymphoma-3 cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation: five-year results of a randomized trial on behalf of the GOELAMS Group.
Arakelyan N; Berthou C; Desablens B; de Guibert S; Delwail V; Moles MP; Quittet P; Jais JP; Colonna P; Andrieu JM;
Cancer; 2008 Dec; 113(12):3323-30. PubMed ID: 18988286
[TBL] [Abstract][Full Text] [Related]
20. Interdigitating dendritic cell sarcoma.
Pokuri VK; Merzianu M; Gandhi S; Baqai J; Loree TR; Bhat S
J Natl Compr Canc Netw; 2015 Feb; 13(2):128-32. PubMed ID: 25691604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
